Enhancing demethylation-induced differentiation in IDH-mutant glioma

Neuro Oncol. 2022 May 4;24(5):724-725. doi: 10.1093/neuonc/noac056.

Authors

Julie J Miller^{1

2}, Daniel P Cahill^{2

3}, Isabel Arrillaga-Romany¹

Affiliations

¹ Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

DNA
Demethylation
Glioma* / genetics
Humans
Isocitrate Dehydrogenase / genetics
Isocitrate Dehydrogenase / metabolism
Tretinoin

Substances

Tretinoin
DNA
Isocitrate Dehydrogenase
IDH1 protein, human

Grants and funding

P50 CA165962/CA/NCI NIH HHS/United States